October 01, 2018
Exploiting the pathophysiology of the gut towards innovative oral drug delivery strategies
Related publications:
- Beloqui, A. et al., A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells. Molecular Pharmaceutics 2016, 13 (12), 4222-4230.
- Xu, Y. et al., Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells. Mol Pharm 2018, 15 (1), 108-115
- Shrestha, N. et al, The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers. Nanoscale 2018, 10 (2), 603-613.
Info : Nathalie Delzenne